SPL 0.47% $2.15 starpharma holdings limited

Gemcitabine and Dep Docetaxel and Dep Cabazitaxel and Dep Gemcitabine

  1. 9,697 Posts.
    lightbulb Created with Sketch. 818
    It's confusing isn't it

    So what we have in pre-clinical trials

    Dep Docetaxel has been used in combination with Gemcitabine

    Dep Cabazitaxel has been used in combination with Gemcitabine

    DEP® gemcitabine has been used alone in studies

    DEP® gemcitabine has been used in combination with Abraxane®


    What are Starpharma's intention in human clinical trials

    Shortly gemcitabine will be used in combination with Dep Docetaxel

    DEP® gemcitabine has been filed at patent office

    I am assuming this will be in the clinic sometime soon

    Hope this clears things up
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
$2.15
Change
0.010(0.47%)
Mkt cap ! $872.9M
Open High Low Value Volume
$2.10 $2.15 $2.06 $1.673M 794.3K

Buyers (Bids)

No. Vol. Price($)
3 25071 $2.14
 

Sellers (Offers)

Price($) Vol. No.
$2.16 11297 1
View Market Depth
Last trade - 16.11pm 25/02/2021 (20 minute delay) ?
(live)
Last
$2.14
  Change
0.010 ( 0.66 %)
Open High Low Volume
$2.08 $2.15 $2.06 138973
Last updated 15.59pm 25/02/2021 (live) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.